EPAM vs LEXXW · P/E 14, rev $2.81B vs rev $705.9K
EPAM Systems Inc (EPAM) versus Lexaria Bioscience Corp (LEXXW) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. LEXXW currently screens at market cap $33.8M.
Not investment advice. Open the EPAM and LEXXW stock pages for the full models.
Not investment advice.